BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/22/2026 3:24:52 AM | Browse: 33 | Download: 5
Publication Name World Journal of Clinical Oncology
Manuscript ID 121645
DOI 10.5306/wjco.121645
Country China
Category Medicine, Research & Experimental
Manuscript Type Review
Article Title Copper homeostasis imbalance and cuproptosis: Emerging targets and strategies for gastrointestinal tumor therapy
Manuscript Source Invited Manuscript
All Author List Zi-Jin Sun, Kai Wang, Jin-Qiao Li, Lin-Jing Song, Kang-Ni Liang, Ting-Lan Cao and Hui-Zhong Jiang
Funding Agency and Grant Number
Corresponding Author Hui-Zhong Jiang, PhD, Professor, Researcher, Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 11 North Third Ring Road East, Beijing 100700, China. jianghz93@126.com
Key Words Gastrointestinal neoplasms; Cuproptosis; Metabolic reprogramming; Ferredoxin 1; Nanomedicine; Traditional Chinese medicine; Gut microbiota
Core Tip Gastrointestinal malignancies exhibit profound metabolic reprogramming and “cuproplasia”, heavily relying on copper homeostasis for progression and drug resistance. Targeting cuproptosis - a ferredoxin 1-mediated cell death causing toxic aggregation of lipoylated proteins like dihydrolipoamide S-acetyltransferase - offers a transformative strategy to bypass conventional therapeutic resistance. This review highlights multifaceted interventions, including repurposing synthetic copper ionophores, leveraging traditional Chinese medicine phytochemicals, and modulating the unique “dietary copper-gut microbiota” axis. Furthermore, deploying stimuli-responsive nanomedicines helps overcome dense stromal barriers and induces immunogenic cell death, synergizing with immunotherapy to advance the precision management of refractory gastrointestinal tumors.
Citation Sun ZJ, Wang K, Li JQ, Song LJ, Liang KN, Cao TL, Jiang HZ. Copper homeostasis imbalance and cuproptosis: Emerging targets and strategies for gastrointestinal tumor therapy. World J Clin Oncol 2026; In press
PDF 121645-in-press.pdf
Received
2026-03-30 08:11
Peer-Review Started
2026-03-30 08:16
First Decision by Editorial Office Director
2026-04-23 09:54
Return for Revision
2026-04-23 10:51
Revised
2026-05-12 08:14
Publication Fee Transferred
Second Decision by Editor
2026-06-22 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-22 03:24
Articles in Press
2026-06-22 03:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com